Oxford-based biotech company Summit Corporation has appointed a new director of sales at Dextra Laboratories.
James Beaumont will oversee the company's plans to deliver more substantial revenues from its carbohydrate chemistry service business. Beaumont was previously vice president of business development at Evotec and brings a wealth of chemistry sales experience to Dextra. During his time there, James delivered manufacturing, process and development chemistry contracts worth in excess of Euro 20m in addition to developing new business in process chemistry R&D, custom synthesis and GMP plant manufacture with multi-national pharmaceutical and biotechnology companies. He has previously held sales positions with the US biotechnology company Genzyme and the US drug delivery technology company, Penwest Pharmaceuticals.
